B

Blueprint Medicines Corp

D
BPMC
USD
-1.24
(-1.2794%)
Market Closed
14,932.00
حجم التداول
-4.55
الربح لكل سهم
-
العائد الربحي
-28.058651
P/E
6,060,894,091.20
حجم السوق
اليوم
-1.2794%
1 اسبوع
-5.715%
1 شهر
7.906%
6 اشهر
-9.213%
12 اشهر
47.837%
بداية السنة
3.651%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Blueprint Medicines Corp

Sector:
Healthcare
Industry:
Biotechnology
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
هل تحتاج مساعدة او لديك استفسار؟